Jetrea
Used for Vitreomacular Adhesion
Used for Vitreomacular Adhesion
Ocriplasmin is a medication used to treat an eye condition called symptomatic vitreomacular adhesion. It only requires one dose and is given as an injection into the eye by a healthcare provider. This medication has been discontinued, so it's no longer available in the United States.
What is Ocriplasmin?
Drug facts
| Common Brands | Jetrea |
|---|---|
| Drug Class | Enzyme |
| Controlled Substance Classification | Not a controlled medication |
| Generic Status | No lower-cost generic available |
| Availability | Discontinued |
Ocriplasmin dosage
Typical dosage for Ocriplasmin
Interactions between Ocriplasmin and other drugs
Ocriplasmin may interact with certain medications or supplements. Always let your doctor and pharmacist know about any other medications or supplements (including prescribed and over-the-counter medications, vitamins, and dietary or herbal supplements) that you are currently taking. The list below does not include all possible drug interactions with Ocriplasmin. Please note that only the generic name of each medication is listed below.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
